Nashville-based IQuity — which analyzes RNA data to develop tools that help physicians diagnose autoimmune diseases — has received a $150,000 grant from the National Institutes of Health’s Small Business Innovation Research program.
The grant will help fund IQuity’s ongoing research into long non-coding RNAs and their usefulness in distinguishing fibromyalgia from rheumatic diseases including rheumatoid arthritis and lupus, according to a release.
IQuity CEO Dr. Chase Spurlock and Chief Science Officer Dr. Thomas Aune bill themselves as among the first researchers to probe a potential link between gene expression in lncRNAs and the presence of autoimmune diseases.
“We took a ‘guilt by association’ approach,” Spurlock said in the release. “We were intrigued by the close proximity of lncRNAs to genes that had been studied for a long time and were very important.”
IQuity launched in early 2016, leveraging Vanderbilt University intellectual property to get operational.
Source – Nashville Post